Inflammatory immune cells predict survival, relapse in multiple myeloma
January 09, 2026
January 09, 2026
ST. LOUIS, Missouri, Jan. 9 -- The Washington University School of Medicine posted the following news release:
* * *
Inflammatory immune cells predict survival, relapse in multiple myeloma
*
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell atlas, which includes robust patient outcome data, provid . . .
* * *
Inflammatory immune cells predict survival, relapse in multiple myeloma
*
A new study maps the immune cell landscape of bone marrow in patients with multiple myeloma, a rare cancer that develops in the plasma cells of the bone marrow and has no cure. This large immune cell atlas, which includes robust patient outcome data, provid . . .